PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

142 hedge funds and large institutions have $415M invested in Progenics Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
142
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.69M
Puts
$1.16M
Net Calls
Net Calls Change

Top Buyers

1 +$8.28M
2 +$6.05M
3 +$4.42M
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
+$3.92M
5
JGC
J. Goldman & Co
New York
+$2.47M

Top Sellers

1 -$4.73M
2 -$3.88M
3 -$3.73M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.84M
5
Wells Fargo
Wells Fargo
California
-$2.83M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$2.75M
27
$2.47M
28
$2.31M
29
$1.74M
30
$1.59M
31
$1.57M
32
$1.41M
33
$1.22M
34
$1.15M
35
$1.13M
36
$1.09M
37
$951K
38
$928K
39
$894K
40
$863K
41
$856K
42
$854K
43
$853K
44
$847K
45
$825K
46
$811K
47
$808K
48
$784K
49
$727K
50
$712K